doc. MUDr. Daniela Žáčková, Ph.D.

Associate professor, Department of Internal Medicine, Hematology and Oncology

Correspondence Address:
Jihlavská 340/20, 625 00 Brno

Phone:	+420 532 23 2838, 3603
E‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 218

2016

Quantitative assessment of the CD26+leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects

ČULEN Martin BORSKÝ Marek NÉMETHOVÁ Veronika RÁZGA Filip SMEJKAL Jiri JURČEK Tomáš DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela WEINBERGEROVÁ Barbora SEMERÁD Lukáš SADOVNIK Irina EISENWORT Gregor HERRMANN Harald VALENT Peter MAYER Jiří RÁČIL Zdeněk

Article in Periodical

Oncotarget, year: 2016, volume: 7, edition: 22, DOI
The novel tyrosine kinase inhibitor ponatinib (iclusig® ) provides new hope for CML patients following previous therapy failure

JABBOUR E. LION T. APPERLEY J. LUCIANO L. ŽÁČKOVÁ Daniela

Article in Periodical

Hematology, year: 2016, volume: 52, edition: 1-2

2015

Can we predict resistance in CML? - a single center experience

RÁZGA Filip NÉMETHOVÁ Veronika MORAVČÍKOVÁ Dagmar RÁČIL Zdeněk ŽÁČKOVÁ Daniela DVOŘÁKOVÁ Dana JURČEK Tomáš MAYER Jiří

Conference abstract

Year: 2015, type: Conference abstract
CD26 antigen is specific for leukemic stem cells in chronic myeloid leukemia and distinguishes patient groups with different ratios of leukemic and healthy stem cells

ČULEN Martin BORSKÝ Marek NÉMETHOVÁ Veronika ŠMEJKAL Jiří JURČEK Tomáš DVOŘÁKOVÁ Dana WEINBERGEROVÁ Barbora SEMERÁD Lukáš ŽÁČKOVÁ Daniela MAYER Jiří RÁČIL Zdeněk

Conference abstract

Year: 2015, type: Conference abstract
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

HAASS W. ŽÁČKOVÁ Daniela KLEINER H. WEISS C. HAFERLACH C. SCHLEGELBERGER B. MULLER M. C. HEHLMANN R. HOFMANN W. K. FABARIUS A. SEIFARTH W.

Article in Periodical

Plos one, year: 2015, volume: 10, edition: 6, DOI
Chronic myeloid leukemia: is the real prognosis of newly diagnosed patients really so good?

ŽÁČKOVÁ Daniela RÁČIL Zdeněk JANOUŠOVÁ Eva DVOŘÁKOVÁ Dana JURČEK Tomáš MINAŘÍK R. PROCHÁZKOVÁ J. OLTOVÁ Alexandra WEINBERGEROVÁ B SEMERÁD L PAVLOVSKÁ L. DUŠEK L MAYER Jiří

Conference abstract

Year: 2015, type: Conference abstract
Chronic myeloid leukemia: is the real prognosis of newly diagnosed patients really so good?

ŽÁČKOVÁ Daniela RÁČIL Zdeněk JANOUŠOVÁ E. DVOŘÁKOVÁ Dana JURČEK T MINAŘÍK R. PROCHÁZKOVÁ J. OLTOVÁ A. WEINBERGEROVÁ Barbora SEMERÁD Lukáš PAVLOVSKÁ L. DUŠEK Ladislav MAYER Jiří

Conference abstract

Year: 2015, type: Conference abstract
Chronická myeloidní leukemie v roce 2015

ŽÁČKOVÁ Daniela

Article in Periodical

Onkologie, year: 2015, volume: 9, edition: 3
Komentář ke studii : Jednoroční a dlouhodobá odpověď na nilotinib a dasatinib u nemocných s CML

ŽÁČKOVÁ Daniela

Article in Periodical

Farmakoterapie, year: 2015, volume: 11, edition: 2
Myeloproliferativní neoplazie

ŽÁČKOVÁ Daniela PENKA Miroslav

Chapter of a book

Onkologie : minimum pro praxi, edition: 1. vyd., year: 2015, number of pages: 10 s.

Projects

Teaching